Phase Study – Medclin Research

Real World Evidence

A CDSCO & ISO-Certified Partner for RWE Studies

Medclin conducts Real-World Evidence studies that bridge real-world clinical practice with scientific evidence.
Our approach combines large-scale real-world data, longitudinal patient follow-ups, and robust analytics to evaluate effectiveness and safety.
The resulting evidence supports regulatory, medical, and strategic decision-making across product lifecycles.

Compliant, and execution-focused RWE capabilities

Clinical leadership driving real-world insights

RWE studies are conceptualized and guided by senior physicians, epidemiologists, and medical affairs experts who translate routine clinical practice into structured, publishable real-world evidence.

RWE study design anchored in real clinical practice

Comprehensive management across pre-study, study, and post-study phases — from protocol development and site initiation to database lock, clinical study reports, and publication in peer-reviewed journals.

Regulatory, ethics & quality compliance

Phase studies conducted under CDSCO-aligned and ISO 9001:2015 certified operations, supported by a robust Quality Management System aligned with ICH-GCP and regulatory requirements.

Large-scale real-world data access & processing

RWE studies leverage structured real-world data from electronic medical records, physical prescriptions, and integrated Rx databases—processed through secure, validated, and scalable data systems.

Integrated phase study services

Medclin conducts both longitudinal and cross-sectional RWE studies, enabling analysis of treatment effectiveness, safety, patient-reported outcomes, and real-world clinical decision-making over time.

Patient-reported outcomes and real-world follow-ups

Flexible phase study design and execution tailored to protocol requirements, therapeutic area needs, and sponsor objectives, supported by strong site intelligence and investigator networks.